Open Access

Additive insulinogenic action of Opuntia ficus-indica cladode and fruit skin extract and leucine after exercise in healthy males

  • Louise Deldicque1,
  • Karen Van Proeyen1,
  • Monique Ramaekers1,
  • Ivo Pischel2,
  • Hartwig Sievers2 and
  • Peter Hespel1Email author
Contributed equally
Journal of the International Society of Sports Nutrition201310:45

https://doi.org/10.1186/1550-2783-10-45

Received: 12 July 2013

Accepted: 10 October 2013

Published: 21 October 2013

Abstract

Background

Oral intake of a specific extract of Opuntia ficus-indica cladode and fruit skin (OpunDia™) (OFI) has been shown to increase serum insulin concentration while reducing blood glucose level for a given amount of glucose ingestion after an endurance exercise bout in healthy young volunteers. However, it is unknown whether OFI-induced insulin stimulation after exercise is of the same magnitude than the stimulation by other insulinogenic agents like leucine as well as whether OFI can interact with those agents. Therefore, the aims of the present study were: 1) to compare the degree of insulin stimulation by OFI with the effect of leucine administration; 2) to determine whether OFI and leucine have an additive action on insulin stimulation post-exercise.

Methods

Eleven subjects participated in a randomized double-blind cross-over study involving four experimental sessions. In each session the subjects successively underwent a 2-h oral glucose tolerance test (OGTT) after a 30-min cycling bout at ~70% VO2max. At t0 and t60 during the OGTT, subjects ingested 75 g glucose and capsules containing either 1) a placebo; 2) 1000 mg OFI; 3) 3 g leucine; 4) 1000 mg OFI + 3 g leucine. Blood samples were collected before and at 30-min intervals during the OGTT for determination of blood glucose and serum insulin.

Results

Whereas no effect of leucine was measured, OFI reduced blood glucose at t90 by ~7% and the area under the glucose curve by ~15% and increased serum insulin concentration at t90 by ~35% compared to placebo (P<0.05). From t60 to the end of the OGTT, serum insulin concentration was higher in OFI+leucine than in placebo which resulted in a higher area under the insulin curve (+40%, P<0.05).

Conclusion

Carbohydrate-induced insulin stimulation post-exercise can be further increased by the combination of OFI with leucine. OFI and leucine could be interesting ingredients to include together in recovery drinks to resynthesize muscle glycogen faster post-exercise. Still, it needs to be confirmed that such nutritional strategy effectively stimulates post-exercise muscle glycogen resynthesis.

Keywords

Nutritional supplementsPost exercise recoveryGlucose clearanceGlycogen resynthesisEndurance athletesAmino acids

Background

High-intensity exercise typically leads to a depletion of body carbohydrate stores, primarily muscle glycogen[1]. Hence high-dose oral carbohydrate intake during recovery after exercise is pivotal to muscle glycogen resynthesis and thus repletion of carbohydrate stores[2]. Therefore, typical sports recovery drinks include a high carbohydrate dose (~50-100 grams), composed of rapidly absorbable sugars such as maltodextrin (a D-glucose polymer) and D-glucose (~dextrose). The increased plasma insulin level due to high-dose glucose ingestion is pivotal to stimulation of muscle glucose uptake and glycogen synthesis[3, 4]. Insulin, which is secreted by the pancreatic β-cells upon elevated circulating glucose concentration, stimulates glucose import in muscle cells via the GLUT4 membrane protein. It also stimulates the incorporation of the glucose molecules into the glycogen molecule via activation of the glycogen synthase enzyme[5]. In this regard it is also important to note that muscular insulin sensitivity is markedly increased following muscle contractions[6]. Thus, any intervention that could elevate plasma insulin and/or further increase insulin sensitivity following exercise could facilitate repletion of muscle glycogen stores, and thus serve as a useful recovery agent.

In this respect, the addition of amino acids, and more particularly leucine, to a carbohydrate-rich drink is a frequent strategy used by athletes to increase insulin secretion and thereby enhance glycogen resynthesis. Leucine has a strong insulinotropic action which contributes to a faster glycogen resynthesis after exercise[7, 8]. Based on recent reports[9, 10], Opuntia ficus-indica intake could be another interesting nutritional strategy to stimulate insulin secretion and glycogen resynthesis after exercise. Opuntia ficus-indica is one of the approximately 200 species of the Opuntia genus, which belongs to the Cactaceae family[11]. Opuntia ficus-indica has been found to lower blood glucose and to increase basal plasma insulin levels in animals[9, 12] as well as in humans[10, 13, 14]. This indicates a direct action on insulin secretion at the site of pancreatic β-cells rather than an indirect action via increased blood glucose levels.

Our group has recently shown that oral intake of a specific extract of Opuntia ficus-indica cladode and fruit skin (OFI) increases serum insulin concentration while reducing blood glucose level for a given amount of glucose ingestion after an endurance exercise bout in healthy young volunteers[10]. In a dose–response experiment we also found 1000 mg of OFI to cause a maximal increase of plasma insulin concentration. However, we did not evaluate the interaction of OFI with other insulinogenic agents like leucine. Moreover, commercial recovery drinks contain a maximal leucine dose of 3 g whereas only high doses (~7 g) have been shown to increase carbohydrate-induced insulin stimulation after exercise[7, 8, 15]. It is unknown whether lower doses of leucine increase carbohydrates-induced insulin stimulation as well. Against this background, the aims of the present study were: 1) to compare the degree of insulin stimulation by OFI with another prevailing strategy in sports nutrition to stimulate post exercise insulin release, i.e. 3 g oral leucine administration; 2) to determine whether OFI and leucine can have an additive action to elevate post exercise plasma insulin concentration.

Methods

Subjects

Eleven healthy, physically active males were included in the study (age: 21.1 ± 0.9 y; body weight: 74.5 ± 4.2 kg; VO2 max: 65 ± 4 ml·min-1·kg). After approval of the study protocol by the local Ethics Committee (KU Leuven), subjects were asked to give their written consent after they were informed of all experimental procedures and risks associated with the experiments. Furthermore, they were submitted to a medical screening before being enrolled in the study. Subjects who had any pathology or were taking any medication or nutritional supplements that were not compatible with the study protocol were excluded. All procedures were carried out in accordance with the Declaration of Helsinki (2000) of the World Medical Association.

Preliminary testing

Two weeks before the start of the study, the subjects performed a maximal incremental exercise test (initial load 60 Watts (W) + 35 W per 3 min) on a bicycle ergometer (Avantronic Cyclus II, Leipzig, Germany) to determine the rate of maximal oxygen uptake (VO2max) and the corresponding workload. Heart rate (Polar, Kempele, Finland), VO2 and VCO2 (Cortex Metalyzer II, Leipzig, Germany) were continuously measured during the test.

Study protocol

A double–blind randomized cross-over study was performed. Subjects participated in four experimental sessions with a 1-week interval in between. Subjects abstained from any high intensity exercise for 48 hours prior to the experiments. In the evening before the experimental sessions, subjects received a standardized carbohydrate-rich dinner (860 kcal, 73% carbohydrates, 14% fat, 13% protein), after which they remained fasted. On the morning of the experiments they reported to the laboratory in the fasted state between 8:00 and 9:00a.m. to perform a 30-min endurance exercise bout at 70% of their previously determined VO2max at a cadence fixed at 90-100 rpm. At the end of the exercise the subjects got seated in a comfortable armchair and an intravenous catheter was inserted into an arm vein for repeated blood sampling during the experiment after which a baseline blood sample was collected. The subjects received capsules containing either: 1) LUVOS Heilerde serving as placebo (PL); 2) 1000 mg Opuntia ficus-indica cladode and fruit skin extract (OFI) (OpunDia™, Finzelberg, Germany); 3) 3 g leucine (LEU) (Ajinomoto, Japan); 4) 1000mg Opuntia ficus-indica extract + 3 g leucine (OFI+LEU). All capsules had identical appearance and the number of capsules ingested was the same for each condition. OpunDia™ is a preferred blend of Opuntia ficus-indica cladode and fruit skin extract containing 75% cladode extract and 25% fruit skin extract (for both extraction solvent: water; DER (drug-to-extract ratio) 2–4:1; 50% native extract, 50% collagen hydrolysate as excipient). All plant materials of Opuntia ficus-indica were obtained from a US American-based cultivation having breeding experience since 1923[16]. Voucher specimens of the drug material are deposited at PhytoLab, Vestenbergsgreuth, Germany. The dose of 1000 mg OFI was selected based on preliminary dose–response data showing 1000 mg to be the lowest dose needed to maximally increase plasma insulin concentration[10]. After ingestion of the supplement together with a 75 g glucose bolus in 300 ml water, a 2-hr oral glucose tolerance test (OGTT) was started at time 0 (t0). Thereafter, a blood sample (5 ml) was collected from the arm vein catheter into vacuum tubes containing Silica clot activator (BD Vacutainer, NJ, USA), at 30, 60, 90, and 120 min. During the OGTT, an additional dose of OFI (1000 mg) and/or LEU (3 g), together with glucose (75 g), was given at t60 to maintain blood glucose concentration high. Blood samples were centrifuged (1500 rpm for 15 min at 4°C) to spin down the serum which was stored at −80°C until analyzed at a later date for insulin.

Blood samples

Serum insulin was assayed by chemiluminescence using the Siemens DPC kit and according to the instructions by the manufacturer. Blood glucose concentration was determined on 10 μl blood coming from the earlobe using an automated micro-analyzer (Arkray Inc., Kyoto, Japan).

Data calculations and statistical analyses

The positive incremental area under the glucose curve and the insulin curve were calculated as previously described[17, 18]. The differences between the conditions (PL, OFI, LEU and OFI+LEU) were analyzed by Student’s paired T-tests using the SigmaPlot® statistical software package. A probability level of P≤0.05 was considered statistically significant. All data are expressed as means ± SE.

Results

OFI and leucine have an additive insulinogenic effect

All subjects tolerated the supplements well and none exhibited symptoms of gastrointestinal distress. Post exercise blood glucose concentration was 4.0 ± 0.1 mmol/l in all experimental conditions (Figure 1A). Thirty minutes following the initial 75 g glucose bolus together with the supplement(s), blood glucose peaked at 6.6 ± 0.1 mmol/l, to gradually decrease thereafter. Compared with PL, OFI reduced blood glucose at t90 by 7% (5.7 ± 0.2 in OFI vs 6.2 ± 0.3 mmol/l in PL, P<0.05, Figure 1A) and the area under the 2-h glucose curve by about 15% (190 ± 24 in OFI vs 233 ± 33mmol/l/2h in PL, P<0.05, Figure 1B). Leucine tended to decrease blood glucose concentration at t90 (P=0.070, Figure 1A). Post exercise serum insulin concentration was 5.7 ± 0.6 mU/l and reached 35-50 mU/l during the OGTT depending on the treatment. From t60 to the end of the OGTT, serum insulin concentration was higher in OFI+LEU than in PL (P<0.05, Figure 1C). OFI alone increased insulin concentration only at t90 (50 ± 10 in OFI vs 36 ± 7 mU/l in PL, P<0.05). Accordingly, OFI+LEU increased by about 40% (4555 ± 923 in OFI+LEU vs 3259 ± 663 mU/l/2h in PL, P<0.05) and OFI alone tended to increase (4272 ± 761 in OFI vs 3259 ± 663 mU/l/2h in PL, P=0.059) the area under the insulin curve (Figure 1D). Leucine had no effect on insulin concentration.
Figure 1

Effect of Opuntia ficus-indica cladode and fruit skin extract and/or leucine on blood glucose and serum insulin during a post exercise OGTT. Concentrations of blood glucose (A) and serum insulin (C), as well as the calculated area under the curve for blood glucose (B) and serum insulin (D) during a 120-min OGTT after exercise and after having ingested a placebo (PL), Opuntia ficus-indica cladode and fruit skin extract (OFI), leucine (LEU) or Opuntia ficus-indica cladode and fruit skin extract + leucine (OFI+LEU). Data are means ± SE (n=11). *P<0.05 vs PL.

Discussion

In a recent study, we showed for the first time that OFI can elevate circulating plasma insulin concentration during high rate carbohydrate ingestion in humans at rest and after exercise[10]. This finding is particularly relevant to endurance athletes seeking to restore high muscle glycogen concentration between training sessions so as to maintain training quality[19]. As muscle glycogen repletion is sensitive to insulin[3], most prominently during the initial hours following an exercise bout[20, 21], it is important for athletes to establish high circulating plasma insulin concentrations during early recovery following a strenuous training. It is of note that muscle insulin sensitivity is enhanced after exercise, which facilitates glycogen resynthesis compared with rest[6]. High rate carbohydrate ingestion, up to 1.0-1.2 g/kg/h for a few hours, is the prevailing nutritional strategy to increase glucose delivery to muscles together with elevated plasma insulin concentration and thereby stimulate glycogen resynthesis[7, 22]. Adding proteins to a carbohydrate load will even speed up glycogen repletion due to the insulinogenic action of proteins and more particularly due to the branched-chain amino acid leucine[7, 8, 15]. Adding 0.4 g casein hydrolysate/kg/h to a drink containing 0.8 g carbohydrates/kg/h more than doubled plasma insulin response compared with only the carbohydrates. Insulin response was even tripled when 0.1 g leucine/kg/h was added to the carbohydrates/casein hydrolysate drink[15]. Similar results were obtained previously, but in those earlier studies both leucine and phenylalanine were added to the supplements, which makes it impossible to isolate the actions of the two amino acids[7, 8]. In the study by Kaastra[15], drinks were not isoenergetic, which may account for the difference in plasma insulin concentration. However, when drinks were prepared to be isocaloric, carbohydrates combined with proteins still induced a higher insulin response than carbohydrates alone[7]. Contrary to those previous studies, our results do not show a clear additional insulinogenic effect of leucine when co-ingested with a high amount of carbohydrates. We deliberately chose a dose of 3 g of leucine instead of ~ 7 g (0.1 g/kg) by others[7, 8, 15] because leucine has a very low palatability, and therefore most commercial sports supplements contain a maximum of 3 g leucine. We also based our decision on a recent report showing that 3.42 g leucine alone, in the absence of carbohydrate intake and at rest, increased plasma insulin concentration by 50% within 30 min before returning to basal levels[23]. It is thus possible that the smaller amount of leucine, compared to previous studies, added to the high amount of glucose (~1 g/kg/h) was not large enough to further enhance plasma insulin concentration in the present study.

Based on our data, 1000 mg OFI had a slightly higher insulinogenic action than 3 g leucine, certainly 30 min after ingestion of the glucose + OFI beverage. OFI seems to stimulate insulin production acutely and rapidly as serum insulin concentrations during the OGTT each time were increased 30 min after OFI ingestion but no more 60 min after OFI intake. The insulinogenic action of OFI thus clearly is short-lived. The largest effect on plasma insulin concentration was obtained by the combined ingestion of OFI plus leucine. Indeed, insulin concentration was persistently elevated during the second hour of the OGTT when OFI and leucine were administered together. In addition, a trend (P=0.09) to increase in insulin concentration was observed in OFI + LEU compared with OFI alone at 60 and 120 min. As blood glucose concentrations were not modified by OFI plus leucine, the increase in insulin did not result from higher blood glucose levels. Our results rather indicate that OFI and leucine directly stimulate pancreatic insulin release, and that the effects of both agents are additive. Whereas the physiological mechanism by which OFI facilitates glucose-induced pancreatic insulin release remains to be elucidated, it is known that leucine increases pancreatic β-cell insulin secretion through: 1) its oxidative decarboxylation; 2) its ability to allosterically activate glutamate dehydrogenase, and 3) its transamination to α-ketoisocaproate[24]. Those events will subsequently lead to an increased tricarboxylic acid-cycle flux, an increased ATP/ADP ratio, the closure of the ATP-sensitive potassium channels, a depolarization of the plasma membrane and the opening of the calcium sensitive channels which will finally cause the secretion of insulin[2527]. Whether OFI increases the tricarboxylic acid-cycle flux in beta-cells as well, or whether it depolarizes the membrane via a different mechanism than leucine remains to be investigated.

The combination of OFI with leucine seems the best option to increase plasma insulin concentrations after exercise and thereby to potentially accelerate glycogen resynthesis. Nevertheless we did not measure any difference in the area under the glucose curve when both treatments were given together compared to placebo, which could indicate that muscle glucose uptake probably is not substantially modified by combined OFI plus leucine administration. Blood glucose concentration during an OGTT reflects the equilibrium between the rate of glucose appearance from the gut and liver, and the rate of disappearance through peripheral glucose uptake. It can be hypothesized that OFI combined with leucine actually increased both processes that resulted in unchanged blood glucose concentrations. However, this is not likely to be the case as the addition of amino acids to a carbohydrate-rich drink was previously shown to decrease the rates of appearance and disappearance of blood glucose instead[15]. As the decreases were equal in amplitude, it was suggested that amino acids-induced insulin stimulation accelerates glycogen resynthesis after exercise by increasing glycogen synthase activity rather than by increasing muscle glucose uptake[15]. Further studies should try to determine whether the higher circulating insulin levels established by combined OFI plus leucine administration together with high rate glucose uptake post exercise, effectively translate into higher glycogen synthase activity and glycogen resynthesis rate following exercise.

Conclusion

Carbohydrate-induced insulin stimulation after exercise can be further increased by the combination of Opuntia ficus-indica cladode and fruit skin extract with leucine. In the perspective of developing optimal nutritional strategies to recover muscle glycogen faster after high-intensity endurance exercise, OFI and leucine could be interesting ingredients to include together in recovery drinks. Still, it needs to be confirmed that such nutritional strategy effectively stimulates post exercise muscle glycogen resynthesis.

Notes

Abbreviations

GLUT4: 

Glucose transporter 4

LEU: 

Leucine

OFI: 

Opuntia ficus-indica cladode and fruit skin extract

OGTT: 

Oral glucose tolerance test

VO2max: 

Maximal oxygen uptake.

Declarations

Acknowledgments

The authors thank all subjects for participating in this study. The authors also thank Dr. Ruud Van Thienen for medical assistance during the experiments. Björn Feistel and Bernd Walbroel from Finzelberg, Germany kindly supplied OpunDia™ extract. PhytoLab GmbH & Co. KG, Vestenbergsgreuth, Germany, sponsored this study.

Authors’ Affiliations

(1)
Exercise Physiology Research Group, Department of Kinesiology, KU Leuven
(2)
PhytoLab GmbH & Co. KG, Vestenbergsgreuth

References

  1. Bergstrom J, Hultman E: Muscle glycogen synthesis after exercise: an enhancing factor localized to the muscle cells in man. Nature. 1966, 210: 309-310. 10.1038/210309a0.View ArticlePubMedGoogle Scholar
  2. Ivy JL, Lee MC, Brozinick JT, Reed MJ: Muscle glycogen storage after different amounts of carbohydrate ingestion. J Appl Physiol. 1988, 65: 2018-2023.PubMedGoogle Scholar
  3. Price TB, Rothman DL, Taylor R, Avison MJ, Shulman GI, Shulman RG: Human muscle glycogen resynthesis after exercise: insulin-dependent and -independent phases. J Appl Physiol. 1994, 76: 104-111. 10.1063/1.357116.View ArticlePubMedGoogle Scholar
  4. Richter EA, Derave W, Wojtaszewski JF: Glucose, exercise and insulin: emerging concepts. J Physiol. 2001, 535: 313-322. 10.1111/j.1469-7793.2001.t01-2-00313.x.PubMed CentralView ArticlePubMedGoogle Scholar
  5. Srivastava AK, Pandey SK: Potential mechanism(s) involved in the regulation of glycogen synthesis by insulin. Mol Cell Biochem. 1998, 182: 135-141. 10.1023/A:1006857527588.View ArticlePubMedGoogle Scholar
  6. Cartee GD, Young DA, Sleeper MD, Zierath J, Wallberg-Henriksson H, Holloszy JO: Prolonged increase in insulin-stimulated glucose transport in muscle after exercise. Am J Physiol. 1989, 256: E494-E499.PubMedGoogle Scholar
  7. van Loon LJ, Saris WH, Kruijshoop M, Wagenmakers AJ: Maximizing postexercise muscle glycogen synthesis: carbohydrate supplementation and the application of amino acid or protein hydrolysate mixtures. Am J Clin Nutr. 2000, 72: 106-111.PubMedGoogle Scholar
  8. van Loon LJ, Kruijshoop M, Verhagen H, Saris WH, Wagenmakers AJ: Ingestion of protein hydrolysate and amino acid-carbohydrate mixtures increases postexercise plasma insulin responses in men. J Nutr. 2000, 130: 2508-2513.PubMedGoogle Scholar
  9. Butterweck V, Semlin L, Feistel B, Pischel I, Bauer K, Verspohl EJ: Comparative evaluation of two different Opuntia ficus-indica extracts for blood sugar lowering effects in rats. Phytother Res. 2011, 25: 370-375.PubMedGoogle Scholar
  10. Van Proeyen K, Ramaekers M, Pischel I, Hespel P: Opuntia ficus-indica ingestion stimulates peripheral disposal of oral glucose before and after exercise in healthy men. Int J Sport Nutr Exerc Metab. 2012, 22: 284-291.PubMedGoogle Scholar
  11. Feugang JM, Konarski P, Zou D, Stintzing FC, Zou C: Nutritional and medicinal use of Cactus pear (Opuntia spp.) cladodes and fruits. Front Biosci. 2006, 11: 2574-2589. 10.2741/1992.View ArticlePubMedGoogle Scholar
  12. Ennouri M, Fetoui H, Bourret E, Zeghal N, Guermazi F, Attia H: Evaluation of some biological parameters of Opuntia ficus indica. 2. Influence of seed supplemented diet on rats. Bioresour Technol. 2006, 97: 2136-2140. 10.1016/j.biortech.2005.09.031.View ArticlePubMedGoogle Scholar
  13. Frati-Munari AC, de LC, Ariza-Andraca R, Banales-Ham MB, Lopez-Ledesma R, Lozoya X: [Effect of a dehydrated extract of nopal (Opuntia ficus indica Mill.) on blood glucose]. Arch Invest Med (Mex ). 1989, 20: 211-216.Google Scholar
  14. Godard MP, Ewing BA, Pischel I, Ziegler A, Benedek B, Feistel B: Acute blood glucose lowering effects and long-term safety of OpunDia supplementation in pre-diabetic males and females. J Ethnopharmacol. 2010, 130: 631-634. 10.1016/j.jep.2010.05.047.View ArticlePubMedGoogle Scholar
  15. Kaastra B, Manders RJ, Van BE, Kies A, Jeukendrup AE, Keizer HA, Kuipers H, van Loon LJ: Effects of increasing insulin secretion on acute postexercise blood glucose disposal. Med Sci Sports Exerc. 2006, 38: 268-275. 10.1249/01.mss.0000183875.86476.bd.View ArticlePubMedGoogle Scholar
  16. Bunch R: New developments in breeding and cactus pear products at D'Arrigo Bros. J Prof Assoc Cactus Dev. 2013, 1: 100-102.Google Scholar
  17. Wolever TM, Jenkins DJ: The use of the glycemic index in predicting the blood glucose response to mixed meals. Am J Clin Nutr. 1986, 43: 167-172.PubMedGoogle Scholar
  18. Wolever TM, Jenkins DJ, Jenkins AL, Josse RG: The glycemic index: methodology and clinical implications. Am J Clin Nutr. 1991, 54: 846-854.PubMedGoogle Scholar
  19. Burke LM, Hawley JA, Wong SH, Jeukendrup AE: Carbohydrates for training and competition. J Sports Sci. 2011, 29 (Suppl 1): S17-S27.View ArticlePubMedGoogle Scholar
  20. Richter EA, Mikines KJ, Galbo H, Kiens B: Effect of exercise on insulin action in human skeletal muscle. J Appl Physiol. 1989, 66: 876-885.PubMedGoogle Scholar
  21. Jensen TE, Richter EA: Regulation of glucose and glycogen metabolism during and after exercise. J Physiol. 2012, 590: 1069-1076.PubMed CentralView ArticlePubMedGoogle Scholar
  22. Beelen M, Burke LM, Gibala MJ, van Loon LJ: Nutritional strategies to promote postexercise recovery. Int J Sport Nutr Exerc Metab. 2010, 20: 515-532.PubMedGoogle Scholar
  23. Wilkinson DJ, Hossain T, Hill DS, Phillips BE, Crossland H, Williams J, Loughna P, Churchward-Venne TA, Breen L, Phillips SM: Effects of Leucine and its metabolite, beta-hydroxy-beta-methylbutyrate (HMB) on human skeletal muscle protein metabolism. J Physiol. 2013, 591: 2911-2923.PubMed CentralView ArticlePubMedGoogle Scholar
  24. Manders RJ, Little JP, Forbes SC, Candow DG: Insulinotropic and muscle protein synthetic effects of branched-chain amino acids: potential therapy for type 2 diabetes and sarcopenia. Nutrients. 2012, 4: 1664-1678. 10.3390/nu4111664.PubMed CentralView ArticlePubMedGoogle Scholar
  25. Newsholme P, Brennan L, Rubi B, Maechler P: New insights into amino acid metabolism, beta-cell function and diabetes. Clin Sci (Lond). 2005, 108: 185-194. 10.1042/CS20040290.View ArticleGoogle Scholar
  26. Sener A, Malaisse WJ: L-leucine and a nonmetabolized analogue activate pancreatic islet glutamate dehydrogenase. Nature. 1980, 288: 187-189. 10.1038/288187a0.View ArticlePubMedGoogle Scholar
  27. Panten U, Kriegstein E, Poser W, Schonborn J, Hasselblatt A: Effects of L-leucine and alpha-ketoisocaproic acid upon insulin secretion and metabolism of isolated pancreatic islets. FEBS Lett. 1972, 20: 225-228. 10.1016/0014-5793(72)80801-9.View ArticlePubMedGoogle Scholar

Copyright

© Deldicque et al.; licensee BioMed Central Ltd. 2013

This article is published under license to BioMed Central Ltd. This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.